The editorial team at LevinPro HC attended BOMA International’s Medical Real Estate Conference last week and sat down with Lorie Damon, who leads the healthcare advisory practice at Cushman & Wakefield. Below is the Q&A of the conversation...
As the healthcare market moves toward a value-based care model, outpatient settings and services will only rise in demand from investors and patients alike. Ambulatory surgery centers, or ASCs, will be one of the most valuable assets in this shift in the healthcare...
We sat down and spoke with industry expert Andre Ulloa, Partner and Executive Advisor of M&A Healthcare Advisors, to discuss the key considerations investors should know before investing in the health clinic market. Ulloa sheds light on the factors driving...
The ear, nose and throat (ENT) market, also known as otolaryngology, encompasses a wide range of services. For our purposes, we categorize all ENT and allergy-related services under the ENT subsector. This classification is based on the comprehensive expertise of...
Historically, nephrology has not seen a large amount of investment activity. In the past few years, there have only been a handful of transactions. According to data captured in the LevinPro HC database, in 2021 there were only five transactions. In 2022, there...
The deal activity of Home Health & Hospice investors has been on a steady decline over the past two years, ever since reaching its peak in the fourth quarter of 2021. There were 95 reported transactions in the 2023 Home Health & Hospice market, which is a 16%...